Cite
HARVARD Citation
Gao, F. et al. (2016). Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa. Cancer biology & therapy. 17 (6), pp. 595-598. [Online].